Diabetes High Among Latinos, but No Single ‘Hispanic’ Profile

An ongoing federally funded study of the health of Hispanics in the United States is yielding nuanced and complex data, with one clear finding: There is no single “Hispanic” profile.

diabetes

The prevalence of the metabolic syndrome overall among the Hispanic groups is 35%, compared with 22.5% in the US population as a whole. And the prevalence of diabetes is 16.9% among Hispanics, compared with 11.3% for all US adults. But this prevalence varies, from just 10.2% among those of South American origin to 18.3% for those with Mexican backgrounds.

And curiously, while Mexicans have the highest rates of diabetes among the Hispanic groups, they join South Americans at the bottom of the list for hypertension (around 20% for both), while those of Caribbean origin (Puerto Rico, Dominican Republic) have the highest hypertension rates (around 30% for both).

The Hispanic Community Health Study (HCHS)/Study of Latinos (SOL) is the largest study of Hispanic health in the United States and began in 2006. There are 16,415 participants aged 18 to 74 at 4 field centers (San Diego; Chicago; Miami; and Bronx, New York), and the trial has now been funded through 2019. Most (79%) were born outside the United States/Puerto Rico.

Mexicans/Mexican-Americans are the largest group, 39%, followed by 17% who self-identified as Puerto Rican, 14% Cuban, 11% Central American, 9% Dominican, 7% South American, and 3% from more than 1 country.

Why Do US Hispanics Live Longer?
Despite lower socioeconomic status and higher rates of cardiovascular risk factors, Hispanics actually live longer than do non-Hispanic whites or African Americans. In 2011, life expectancy for Hispanics overall was 81.4 years, compared with 78.7 years for the US population as a whole. Hispanic women have the highest life expectancy, 83.7 years, according to data from the Centers for Disease Control and Prevention

Dr. Avilés-Santa said the data so far indicate that doctors need to watch out for a high burden of risk factors and for diabetes at a young age among different Latino groups.
They also need to be on the lookout for hypercholesterolemia and for cardiac structural abnormalities prior to a clinical diagnosis of diabetes. Other important findings include the fact that many older Hispanic people have unrecognized diabetes, and there are issues around sleep-disordered breathing and unrecognized dyspnea and pulmonary disease.

Read more at: http://www.medscape.com/viewarticle/825392

COURTESY: MEDSCAPE – For the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more!

Chronic Migraine Responds to OnabotulinumtoxinA

OnabotulinumtoxinA (Botox, Allergan Inc) continues to relieve migraine headache when given over the long term, according to a retrospective analysis of patients with chronic migraine treated for 9 treatment cycles, 12 weeks apart.

botox to treat migraines

“Doctors can now tell their patients that Botox is a safe and effective treatment for chronic migraine, with data now reported over 9 treatment cycles, almost double the duration of the previous data set from earlier studies,” Andrew Blumenfeld, MD, from the Headache Center of Southern California, Encinitas, California, told Medscape Medical News.

Read more at: http://www.medscape.com/viewarticle/825002